Traverse Therapeutics, Inc. (TVTX) - Eric Dube files Form 144
- Filer: Eric Dube
- Shares to be sold: 243,735
- Aggregate market value: $12,983,763.45
Eric M Dube, reporting
TVTX
Travere Therapeutics, Inc. SEC filings
Every EDGAR filing for Travere Therapeutics, Inc. (TVTX), newest first, with AI summaries and stories.
- Ticker
- TVTX
- CIK
- 1438533
- Sector
- Biotech and pharma
- Latest filing
- 3d
Next: 10-Q expected ~Nov 2 (deadline Nov 9) · earnings expected ~Nov 4
Filings
144Travere Therapeutics, Inc.TVTXLIVE 8-KTravere Therapeutics, Inc.TVTXLIVE 4Travere Therapeutics, Inc.TVTXLIVE 7 insider filings
Sandra Calvin, insider filing for TVTX
Show all 7
- 4Insider filing for TVTX
- 4Insider filing for TVTX
- 4Insider filing for TVTX
- 4Insider filing for TVTX
- 4Insider filing for TVTX
- 4Insider filing for TVTX
- 4Insider filing for TVTX
Sandra Calvin, reporting
144Travere Therapeutics, Inc.TVTXLIVE 2 Form 144 notices
Eric M Dube, planned sale of TVTX shares
Show all 2
- 144Planned insider sale of TVTX shares
- 144Planned insider sale of TVTX shares
Eric M Dube, reporting
144Travere Therapeutics, Inc.TVTXLIVE 3 Form 144 notices
Eric M Dube, planned sale of TVTX shares
Show all 3
- 144Planned insider sale of TVTX shares
- 144Planned insider sale of TVTX shares
- 144Planned insider sale of TVTX shares
Eric M Dube, reporting
144Travere Therapeutics, Inc.TVTXLIVE 7 Form 144 notices
Sandra Calvin, planned sale of TVTX shares
Show all 7
- 144Planned insider sale of TVTX shares
- 144Planned insider sale of TVTX shares
- 144Planned insider sale of TVTX shares
- 144Planned insider sale of TVTX shares
- 144Planned insider sale of TVTX shares
- 144Planned insider sale of TVTX shares
- 144Planned insider sale of TVTX shares
Sandra Calvin, reporting
4Travere Therapeutics, Inc.TVTXLIVE Jeffrey A Meckler, insider filing for TVTX
Jeffrey A Meckler, reporting
144Travere Therapeutics, Inc.TVTXLIVE Jeffrey A Meckler, planned sale of TVTX shares
Jeffrey A Meckler, reporting
4Travere Therapeutics, Inc.TVTXLIVE Christopher R. Cline, insider filing for TVTX
Christopher R. Cline, reporting
4Travere Therapeutics, Inc.TVTXLIVE Gary A Lyons, insider filing for TVTX
Gary A Lyons, reporting
144Travere Therapeutics, Inc.TVTXLIVE Gary A Lyons, planned sale of TVTX shares
Gary A Lyons, reporting
144Travere Therapeutics, Inc.TVTXLIVE Gary A Lyons, planned sale of TVTX shares
Gary A Lyons, reporting
SCHEDULE 13G/ATravere Therapeutics, Inc.TVTXLIVE Ownership stake disclosure by ARMISTICE CAPITAL, LLC (amended)
ARMISTICE CAPITAL, LLC, filed by
SCHEDULE 13GTravere Therapeutics, Inc.TVTXLIVE Ownership stake disclosure by BANK OF AMERICA CORP /DE/
BANK OF AMERICA CORP /DE/, filed by
SCHEDULE 13GTravere Therapeutics, Inc.TVTXLIVE Ownership stake disclosure by STATE STREET CORP
STATE STREET CORP, filed by
SCHEDULE 13G/ATravere Therapeutics, Inc.TVTXLIVE Ownership stake disclosure by FMR LLC (amended)
FMR LLC, filed by
10-QTravere Therapeutics, Inc.TVTXLIVE 8-KTravere Therapeutics, Inc.TVTXLIVE 8-KTravere Therapeutics, Inc.TVTXLIVE 4Travere Therapeutics, Inc.TVTXLIVE Jula Inrig, insider filing for TVTX
Jula Inrig, reporting
S-8Travere Therapeutics, Inc.TVTXLIVE 4Travere Therapeutics, Inc.TVTXLIVE 2 insider filings
Timothy Coughlin, insider filing for TVTX
Show all 2
- 4Insider filing for TVTX
- 4Insider filing for TVTX
Timothy Coughlin, reporting
8-KTravere Therapeutics, Inc.TVTXLIVE 144Travere Therapeutics, Inc.TVTXLIVE Roy D. Baynes, planned sale of TVTX shares
Roy D. Baynes, reporting
144Travere Therapeutics, Inc.TVTXLIVE Timothy Coughlin, planned sale of TVTX shares
Timothy Coughlin, reporting
8-KTravere Therapeutics, Inc.TVTXLIVE 4Travere Therapeutics, Inc.TVTXLIVE 8 insider filings
Roy D. Baynes, insider filing for TVTX
Show all 8
- 4Insider filing for TVTX
- 4Insider filing for TVTX
- 4Insider filing for TVTX
- 4Insider filing for TVTX
- 4Insider filing for TVTX
- 4Insider filing for TVTX
- 4Insider filing for TVTX
- 4Insider filing for TVTX
Roy D. Baynes, reporting